Verano Holdings Corp.
5.12USD
+0.1500 (+3.02%)
Computing valuation metrics…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on VRNO.
Valuation
P/E (TTM)
—
P/E (Forward)
9.60x
EV/EBITDA
4.47x
EV/Revenue
0.93x
P/S (TTM)
0.45x
P/B
0.55x
FCF Yield
12.19%
Dividend Yield
0.00%
Gross Margin
47.83%
Operating Margin
-15.81%
Net Margin
-30.94%
Peer Comparison — Drug Manufacturers - Specialty & Generic
| Company | Mkt Cap | P/E | EV/EBITDA | FCF Yield | Rev Growth | Div Yield |
|---|---|---|---|---|---|---|
| VRNOVerano Holdings Corp. | $374.88M | — | 4.47x | 12.19% | 7.74% | 0.00% |
| TEVATeva Pharmaceutical Industries Limited | $47.11B | 67.32x | 14.13x | 4.71% | -0.80% | 0.00% |
Subject metrics from SEC filings where available; peer metrics from cached market data.
| $32.33B |
| 12.87x |
| 9.81x |
| 6.24% |
| -0.20% |
| 2.62% |
| UTHRUnited Therapeutics Corporation | $25.36B | 21.17x | 15.17x | 2.20% | -1.90% | 0.00% |
| VTRSViatris Inc. | $21.50B | — | 7.83x | 12.45% | 4.90% | 2.62% |
| HIMSHims & Hers Health, Inc. | $6.44B | — | — | 13.20% | 38.20% | 0.00% |
| KNSAKiniksa Pharmaceuticals International, plc | $5.61B | 73.72x | 50.74x | 2.25% | 55.40% | 0.00% |
| LQDALiquidia Corporation | $3.92B | 31.47x | 22.46x | 1.90% | 1842.70% | 0.00% |
| RGCRegencell Bioscience Holdings Limited | $3.70B | — | — | -0.08% | — | 0.00% |